FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19

FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19

FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency

In response to the Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing answers to Frequently Asked Questions regarding the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder for new and existing patients.